Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

247.35
Delayed Data
As of Feb 17
 +0.42 / +0.17%
Today’s Change
184.50
Today|||52-Week Range
301.32
+17.78%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Operating ActivitiesNet Income / Starting Line256.4M-499.9M15.2B--
 
 
 
 
Depreciation1.6B1.7B1.6B--
 
 
 
 
Total Other Cash Flow204.8M429.3M-18.2B--
 
 
 
 
Funds From Operations1.6B1.8B-1.6B--
 
 
 
 
Funds From/For Other Operating Expenses357.7M402.4M-459.8M--
 
 
 
 
Net Cash Flow - Operating Activities1.2B1.4B-1.1B-108.6M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.00-15.4B--
 
 
Decrease In Investments19.0M6.5M----
 
 
 
Capital Expenditures-84.9M-97.9M-67.7M--
 
 
 
 
Fixed Asset Disposal12.1M2.4M33.3B--
 
 
 
 
Net Assets From Acquisitions 0.000.00-74.5M--
 
 
Other Investing - Sources0.000.0040.0M--
 
 
Net Cash Flow Investing-53.8M-89.0M17.8B6.7B
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings900.0M0.00150.0M--
 
 
 
Long Term Debt Reduction-854.2M-3.0B-7.0B--
 
 
 
 
Net Proceeds Stock Sale69.6M37.7M30.7M--
 
 
 
 
Common Preferred Redeemed-53.2M-14.1M-2.7B--
 
 
 
 
Common Dividends----------
Cash Dividends Paid - Total-69.6M-69.6M-69.6M--
 
 
 
 
Other Sources - Financing34.6M-2.7M-5.3M--
 
 
 
 
Other Uses - Financing32.3M31.5M13.9M--
 
 
 
 
Net Cash Flow - Financing-5.1M-3.1B-9.6B-12.4B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash5.2M-3.2M2.3M-4.3M
 
 
 
 
 
 
Net Change In Cash1.2B-1.8B7.1B-5.9B